 |
|
|
| |
Relationship between combination of baseline viral load and CD4 cell count, and Week 48 or 96 responses to rilpivirine (RPV)or efavirenz (EFV) in treatment-naïve HIV-1-infected adults: pooled analysis from the Phase III ECHO and THRIVE trials
|
| |
| |
Reported by Jules Levin
19th Conference on Retroviruses and Opportunistic Infections, Seattle, WA, USA, March 5-8 2012
Calvin Cohen,1 Jean-Michel Molina,2 Dushyantha Jayaweera,3 Jaime Andrade-Villanueva,4 Guy De La Rosa,5 Marita Stevens,6 Simon Vanveggel,6 Peter Williams,6 Katia Boven7
1Community Research Initiative of New England, Boston, MA, USA; 2Department of Infectious Diseases, Saint-Louis Hospital and University of Paris, France; 3University of Miami, Miami, FL, USA; 4Hospital Civil de Guadalajara, Guadalajara, Jalisco, Mexico;5Janssen Global Services, Titusville, NJ, USA; 6Janssen Infectious Diseases BVBA, Beerse, Belgium; 7Janssen Research and Development, LLC , Titusville, NJ, USA
|
| |
|
|
|
|
|
